4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-26-121410
Chief Operating Officer acquired 40,693 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
LaChapelle Robin · Chief Operating Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 1 in the form | +16,265 | $3.65 | $59,374 | 152,001 | D |
| 2026-10-30 | Exercise or conversion : show line 2 in the form | +410 | $2.28 | $935 | 152,411 | D |
| 2026-10-30 | Exercise or conversion : show line 3 in the form | +4,550 | $2.28 | $10,381 | 156,961 | D |
| 2026-10-30 | Exercise or conversion : show line 4 in the form | +1,820 | $2.28 | $4,152 | 158,781 | D |
| 2026-10-30 | Exercise or conversion : show line 5 in the form | +17,648 | $6.24 | $110,055 | 176,429 | D |
Table II: Derivative
5 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-10-30 | Exercise or conversion : show line 6 in the form Stock Option (right to buy) | −410 | 0 | D |
| 2026-10-30 | Exercise or conversion : show line 7 in the form Stock Option (right to buy) | −4,550 | 1,820 | D |
| 2026-10-30 | Exercise or conversion : show line 8 in the form Stock Option (right to buy) | −1,820 | 0 | D |
| 2026-10-30 | Exercise or conversion : show line 9 in the form Stock Option (right to buy) | −16,265 | 2,600 | D |
| 2026-10-30 | Exercise or conversion : show line 10 in the form Stock Option (right to buy) | −17,648 | 38,823 | D |
Loading xslF345X06/tm2628786-1_4seq1.xml…